Claris Biotherapeutics, Inc. — Form D

Claris Biotherapeutics, Inc. of HALF MOON BAY, CA, a company, filed a Form D exempt-offering notice with the SEC on 2026-08-07. The offering totals $121.5M, of which $55.7M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (26)

Showing 25 of 26 people.

NameRoleLocation
Clarke AtwellRelated PersonHalf Moon Bay, CA
Brian BaumRelated PersonHalf Moon Bay, CA
Stephen BradyRelated PersonHalf Moon Bay, CA
Reza DanaRelated PersonHalf Moon Bay, CA
Marc de GaridelRelated PersonHalf Moon Bay, CA
Michael DybbsRelated PersonHalf Moon Bay, CA
Meredith FisherRelated PersonHalf Moon Bay, CA
Kenneth HarrisonRelated PersonHalf Moon Bay, CA
Matt HobsonRelated PersonHalf Moon Bay, CA
Susan OrrRelated PersonHalf Moon Bay, CA
Maha RadhakrishnanRelated PersonHalf Moon Bay, CA
Henry RathRelated PersonHalf Moon Bay, CA
Reza DanaDirectorHalf Moon Bay, CA
Meredith FisherDirectorHalf Moon Bay, CA
Kenneth HarrisonDirectorHalf Moon Bay, CA
Henry RathExecutive OfficerHalf Moon Bay, CA
Susan OrrExecutive OfficerHalf Moon Bay, CA
Clarke AtwellDirectorHalf Moon Bay, CA
Clarke AtwellExecutive OfficerHalf Moon Bay, CA
Marc de GaridelDirectorHalf Moon Bay, CA
Marc Clarke de GaridelDirectorJersey City, NJ
Anton Clarke AtwellDirectorJersey City, NJ
Anton Clarke AtwellExecutive OfficerJersey City, NJ
Meredith Clarke FisherDirectorJersey City, NJ
Kenneth Clarke HarrisonDirectorJersey City, NJ

Other filings by this issuer (6)

FiledFormOfferingSold
2025-09-22D$2.3M$2.3M
2025-03-07D$3.3M$3.3M
2024-01-08D$10.0M$10.0M
2023-10-24D/A$44.5M$44.5M
2021-07-14D/A$38.5M$38.5M
2020-04-27D$26.0M$11.8M

More